DOD-CDMRP: Lung Cancer Research Program – Pre-applications

- Career Development Award: Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher. Clinical trials not allowed. Preliminary data not required. Military relevance strongly encouraged. Eligibility: Independent investigators at the level of Assist. Professor; must be within 5 years of first faculty appointment; Have not received a Career Development Award previously from CDMRP; Have not received more than $300K for other lung cancer research as PI. Mentor - At or above the level of Assoc. Professor; Have proven publication and funding record in lung cancer research. Funding: $400K / 3 years.
- Clinical Exploration Award
Clinical Trials: Supports rapid execution of hypothesis-driven, early-phase clinical trials to examine interventions that could have a major impact on lung cancer clinical management. Proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in lung cancer. Funding: $450K / 3 years.
Correlative Studies: Supports innovative, hypothesis-based correlative studies that derive from ongoing or completed clinical trials that have the potential to significantly inform treatment strategies, identify subset of patients for treatment with specific therapies, provide increased understanding of biological changes resulting from the intervention in lung cancer, or provide other insights that will significantly enhance clinical management of lung cancer. Funding: $250K / 2 years.
The application must include documentation of an existing Investigational New Drug (IND) or Investigational Device Exemption (IDE), if applicable. The study is expected to begin no later than 12 months after the award date. Military relevance strongly encouraged.
- Idea Development Award: Supports new ideas that are in the early stages of development representing innovative, highrisk/high-gain research. Emphasis is on innovation and impact. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged. Funding: $350K / 3 years.
https://ebrap.org/eBRAP/public/Program.htm